Nicholas Investment Partners’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-46,541
Closed -$2.84M 180
2019
Q4
$2.84M Buy
46,541
+25,344
+120% +$1.54M 0.29% 105
2019
Q3
$869K Buy
21,197
+14,533
+218% +$596K 0.07% 192
2019
Q2
$314K Buy
+6,664
New +$314K 0.03% 204
2018
Q4
Sell
-86,353
Closed -$3.83M 223
2018
Q3
$3.83M Sell
86,353
-280
-0.3% -$12.4K 0.31% 128
2018
Q2
$5.09M Buy
86,633
+6,143
+8% +$361K 0.36% 80
2018
Q1
$3.68M Buy
+80,490
New +$3.68M 0.26% 126